Addition of GSK126, a potent and selective small molecule inhibitor of EZH2 activity, decreases H3K27me3, reactivates PRC2-suppressed genes, such as, BLIMP1 (a tumor suppressor) and induces cytotoxicity in these lymphoma cells [8]. Here, EZH2 is linked to neoplasm.